cablivi(caplacizumab)Medication DetailsGenzyme CorporationUsage: CABLIVI is indicated for treating adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), used alongside plasma exchange and immunosuppressive therapy.Medication DetailsDrug Interactions